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Abstract
Background: In COPD patients, fatal and non-fatal respiratory-related events are influenced by age, severity of respiratory
disease, and comorbidities.
Objectives: Analyze the effects of edentulism, periodontal disease and systemic biomarkers of inflammation on the
occurrence of serious fatal and non-fatal respiratory-related events among subjects with COPD.
Methods: Cases were identified from Dental Atherosclerosis Risk in Communities study. Edentulism was defined as study
participants without any natural teeth or implants. Participants with one or more natural teeth (comprising 11,378 subjects)
were studied as dentate subjects. Periodontal disease status among dentate individuals was determined using the
consensus definitions published by the joint Center for Disease Control/American Association of Periodontology working
group). Adjusted Hazard Models are developed to evaluate the relationship between edentulism/periodontal disease and
COPD Related Events. Models were then stratified by GOLD Stage I, II and III/IV. Serum biomarkers were also evaluated to
explore the effect of systemic inflammation.
Results: A statistically significant association was found between oral health status and COPD-related events, even adjusting
for conditions such as hypertension, smoking and diabetes. Edentulous individuals who had been diagnosed with COPD
had a higher incidence and were at greater risk of having a COPD related event (hospitalization and death) than individuals
who had teeth and whose mouths had healthy periodontal status. However, being edentulous did not convey excess risk
for COPD-related events for those study participants who were classified as GOLD III/IV at baseline. Finally, we showed that
individuals who had levels of serum IL-6 in the highest two quartiles were at even higher risk for COPD-related events.
Conclusions: These findings suggest that the risk for COPD-related events after adjusting for potential confounders may be
attributable to both edentulism and elevated serum IL-6 levels.
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Introduction
Non-Communicable Diseases (NCDs) including chronic respi-
ratory diseases, together with diabetes, cancer and cardiovascular
diseases, are the leading cause of disease burden and mortality in
the world. Chronic obstructive pulmonary disease (COPD) is the
fifth leading cause of death world-wide and the third leading cause
of death in the United States, affecting as many as 24 million
Americans and resulting in 700,000 hospital admissions, and
124,000 deaths annually [1]. COPD, which is considered the
major respiratory NCD with a 10.1% prevalence of stage II or
higher COPD has been associated with low-grade systemic
inflammation [2,3]. Thus, although COPD is primarily charac-
terized by airflow limitation that is generally associated with an
abnormal inflammatory response in the lungs, it is also often
associated with a significant systemic inflammatory response which
has been correlated with adverse clinical effects [4].
The link between oral infection and various respiratory diseases
in the dentate population has been the focus of several studies
[5,6], more recently, Preshaw et al [7] presented a review focused
on the association of oral and systemic health as it relates to health-
related quality of life .
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Data from our research group demonstrated a significant
association between prior COPD and edentulism [8] . This
observation correlates well with a study that resulted in the
identification of diverse microbes, including respiratory pathogens
on the surfaces of dentures [9].
In addition to its association with an inflammatory response of
the lung, COPD is also associated with systemic inflammation,
including systemic oxidative stress, activation of circulating
inflammatory cells and increased levels of inflammatory cytokines
[9]. Levels of inflammatory biomarkers such as C-reactive protein
(CRP), Interleukin-6 (IL-6) and sICAM-1 have been reported to
be elevated in COPD [10,11,12]. By improving our understanding
of this association with the potential for reducing the incidence of
COPD through treatment of periodontal diseases, which would
have important public health and clinical implications, in the
present study we focused on analyzing the effects of edentulism,
periodontal disease and systemic biomarkers of inflammation on
the occurrence of serious fatal and non-fatal respiratory-related
events among subjects with COPD. The study population was that
of the Atherosclerosis Risk in Communities (ARIC) Study [13].
Methods
Study Population
The ARIC study included 15,792 individuals aged 45 to 64
years selected from four U.S.A. communities. This prospective
cohort study has been previously described in greater detail. (The
ARIC Investigators, 1989). For the current study, data from
individuals participating in the Dental Atherosclerosis Risk in
Communities (D-ARIC) study were also used to examine the
associations between edentulism, periodontal disease, and systemic
biomarkers of inflammation, and the risk of serious fatal and
nonfatal COPD-related events. The D-ARIC was a cross-sectional
investigation conducted in a subset of dentate participants at Visit
4 (1996–1998). Eligible participants were all aged 45–64 at study
entry (i.e., Visit 1) and had spirometry measurements at Visit 2 (3
years later) and periodontal examinations at D-ARIC Visit 4 (6
years from visit 2). Edentulous individuals at Visit 4 were also
eligible for inclusion. Lastly, all individuals were required to have
at least 1 year of follow-up subsequent to Visit 4.
COPD Definition
Based on spirometry measurements obtained at Visit 2,
individuals were considered to have COPD if they had a ratio
of forced expiratory volume in 1 second (FEV1) to forced vital
capacity (FVC) less than 0.7. Subsequently, individuals with
COPD were further categorized by disease severity, using the
spirometry-based criteria for severity outlined in the Global
Initiative for Chronic Obstructive Lung Disease (GOLD) guide-
lines (Table 1). (Global Initiative for Chronic Obstructive Lung
Disease (GOLD), 2007).
COPD-Related Event
The primary endpoint for this study was the occurrence of
COPD-related events (e.g., hospitalization for COPD exacerba-
tion) or COPD-related death during the 5-year period following
Visit 4. In order to be considered related to COPD, a
hospitalization was required to have an ICD9 code for COPD
(491.xx, 492.x, or 496.x) entered in the discharge notes. Similarly,
a death was considered COPD-related if any of the above listed
ICD9 codes were included as a primary cause, secondary cause or
underlying cause.
Edentulism and Periodontal Disease
Edentulism cases were defined as study participants without any
natural teeth or implants. Participants with one or more natural
teeth (comprising 11,378 subjects) were selected as dentate
subjects. Periodontal disease status among dentate individuals
was determined using the consensus definitions published by the
joint Center for Disease Control/American Association of
Periodontology/(CDC/AAP) working group. Periodontal disease
severity was determined based on clinical attachment level (CAL)
and probing depth (PD) according to the criteria described in
Table 2.
Systemic Immune Mediators
Interleukin-6 (IL-6), C-reactive protein (CRP), and soluble
intercellular adhesion molecule 1 (sICAM-1) concentrations from
once thawed serum aliquots (frozen at 280C from collection until
December, 2009) were all measured by ELISA techniques.
Spectrophotometric endpoints were determined on a SpectraMax
M2 plate reader (Molecular Probes, Sunnyvale, CA) using reagent
assay kits from R&D Systems (Minneapolis, MN) according to
manufacturer’s instructions. The SoftmaxH (v.5.0.1) control
software package was used to fit the standard curve data using
either 4-PL or 5-PL fitting algorithms to provide a best fit of the
seven-point (duplicate) standard curve after subtraction of the
mean reagent blank values from all measured optical densities.
Standard curve concentrations ranged from 0.156–10 pg/ml for
serum IL-6, 780–50,000 pg/ml for CRP, and 1,560–50,000 pg/
ml for sICAM-1. Subsequently, the immune mediator concentra-
tions were computed by application of the standard curve fitting
equation.
Other Covariates
Participants of this study were additionally characterized with
respect to research center (Jackson, Mississippi; North Carolina;
Washington; Minnesota), race (African American, Caucasian),
age, sex, and body mass index. History of diabetes and
hypertension were also included in the analysis, as well as income
and education as measures of socioeconomic status. Self-reported
smoking data (both cigarettes and cigars) collected at Visit 4 was
examined as a categorical variable (e.g., current, former, and
never). Additionally, pack-years of smoking were calculated for
current and former smokers.
Statistical Analysis
Patient characteristics were compared between those with and
without a COPD related event using chi-squared tests and t-tests
for categorical variables and continuous variables, respectively.
Kaplan-Meier curves were constructed for each periodontal
disease and edentulous status patient group to examine the time
Table 1. Spirometric Classification of COPD Severity Based on
Post-Bronchodilator FEV1.
GOLD Stage Spirometry Criteria
Stage I FEV1/FVC ,0.7 and FEV1 $80%
predicted
Stage II FEV1/FVC ,0.7 and 50% # FEV1 ,80%
Stage III FEV1/FVC ,0.7 and 30% # FEV1 ,50%
Stage IV FEV1/FVC ,0.7 and FEV1 ,30%
doi:10.1371/journal.pone.0068592.t001
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to COPD related event; differences between Kaplan-Meier curves
were compared using the log-rank test. Cox proportional hazards
regression was used to compute hazards ratios (HR) and 95%
confidence intervals for COPD-related events. In addition to the
crude model, a minimally adjusted and a fully adjusted model
were also specified; covariates were selected for inclusion into the
model a priori or based on bivariate analyses. To measure
modification due to COPD severity, the above models were also
stratified by COPD GOLD Stage (I, II, III/IV). All analyses were
performed using the SAS software, version 9.1 (SAS Institute Inc,
Cary, NC). A two-sided P value of ,0.05 was considered
statistically significant.
Results
The purpose of this investigation was to determine the effects of
edentulism (total loss of teeth), periodontal disease and systemic
biomarkers of inflammation on COPD events in a cohort
population with spirometry-identified COPD. The participant
flow diagram with explanations for inclusion and exclusion
appears in Figure 1. Among the 15,792 ARIC participants there
were a total of 1635 subjects with GOLD stage I,II or III/IV
COPD with known dentate status (with or without teeth) and full-
mouth periodontal examination data for those with teeth. There
were a total of 440 edentulous subjects and 1195 dentate subjects
who were followed for events over a 5 year period with an overall
event rate of 24.4% as shown in Table 3. Oral health status was
significantly related to events (p,0.0001) with event rates
demonstrating a gradient as related to worsening of oral health
from a rate of 10.5% among dentate, periodontally healthy
individuals increasing to 23.8% among those with severe
periodontal disease with the highest rate of COPD events among
those who have lost all teeth due to oral diseases (43.9%). As
expected, there was an increased event rate with increased GOLD
stage, p,0.0001 with those having GOLD Stage III/IV disease
experiencing approximately 3.4 times the event rate as those with
GOLD stages I–II. COPD subjects who experienced events were
more likely to be Caucasian, younger, male, diabetic, hyperten-
sive, tobacco user (current or former), low income and less
educated.
The unadjusted Kaplan Meier Curve showing the event rates
for COPD hospitalization/death for all subjects with GOLD
Table 2. Periodontal Disease Severity defined by clinical parameters.
Clinical Definition
Disease Category CAL PD
Severe periodontitis $2 interproximal sites with CAL $6 MM
(not on same tooth)
And $1 interproximal site with PD
$5 mm
Moderate periodontitis (i.e., Entry) $2 interproximal sites with CAL $4 mm
(not on same tooth)
Or $2 interproximal sites with PD
$5 mm (not on same tooth)
No or mild periodontitis (i.e., including
healthy and gingivitis)
Neither ‘‘moderate’’ nor ‘‘severe’’ periodontitis
doi:10.1371/journal.pone.0068592.t002
Figure 1. Study Subjects Analyzed.
doi:10.1371/journal.pone.0068592.g001
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stages of I, II and III/IV appear in Figure 2. As suggested by the
dentate status and periodontal disease data in Table 3, the survival
function clearly separated periodontal health from edentulous
individuals, while those with Entry and Severe forms of
periodontal disease exhibited intermediate survival functions.
Overall, the oral health status has a dramatic effect on unadjusted
event-free survival rates among COPD subjects with a log rank p-
value of ,0.0001. However, the effects of adjustment for relevant
covariates and confounders on these trends are shown in Table 4.
Cox proportional hazards models using the periodontally healthy
dentate group as the referent population in unadjusted models
demonstrate a clear trend and a gradient with increasing
periodontal disease severity increasing the hazards ratios (HR)
from 1.90 (95% confidence interval: 1.28–2.83) to 2.22 (1.44–3.41)
and 4.66 (3.21–6.78) for edentulism. After adjustment for relevant
confounders from Table 1 including age, race, center, gender and
smoking, only edentulism remains a significant risk factor for
events with a hazard ratio of 2.45 (1.61–3.74). Inclusion of
additional variables in the final model did not contribute to the
overall fit of the model.
The effects of oral health status on COPD-related events are
stratified by GOLD stage in Table 5. In unadjusted models for
GOLD stage I subjects there is an apparent trend of increasing
hazard ratio associated with periodontal disease severity with the
highest risk observed in the edentulous individuals [HR = 5.06
(2.60–9.85)]. However, after adjustment for center, race, gender,
age, smoking, education and BMI, only edentulism remained
statistically significant albeit with attenuated risk [HR = 2.37
(1.03–5.45)]. The effect of oral disease on events for subjects with
GOLD stage II demonstrated a similar pattern as GOLD I
subjects, with a comparable magnitude of risk [HR = 2.12 (1.17–
3.83)] for edentulous subjects. There was no association between
oral status and events among GOLD stage III/IV subjects
(Table 5).
Serum biomarkers of inflammation including IL-6, CRP and
sICAM-1 have been associated with periodontal disease and
COPD morbidity. Table 6 and 7 explore the potential role of these
systemic mediators as intermediary explanatory variables that link
the observed association between oral disease and COPD
morbidity. Subjects with higher levels of serum IL-6, CRP or
sICAM had higher event rates (Table 6). For example, subjects
with the lowest levels of IL-6 (lowest quartile) experienced lower
event rates (7.5%) as compared to subjects in the highest quartile
of serum IL-6 (41.8%). All three biomarkers were associated with
statistically significantly higher event rates when elevated in the
highest quartile; however, these significant trends are unadjusted.
The models that include oral health status and serum IL-6 levels
by quartiles, and another that includes oral health status and
quartile of serum CRP are shown in Table 7. Models that include
oral health status and sICAM are not shown because no significant
associations with events were observed. Table 7 displays unad-
justed and fully adjusted Models. These Cox Proportional Hazards
models include both oral disease status using Periodontal Health as
the referent group and the lowest quartile of IL-6 or CRP as the
referent group. In the unadjusted IL-6 model severe periodontal
disease and edentulism as well as all three of the upper quartiles of
IL-6 remain significantly associated with increased HR. There is a
gradient response noted with increasing IL-6 levels. In the fully
adjusted models severe periodontal disease is no longer signifi-
cantly associated with increased risk, but edentulism remains
significant [HR = 2.66 (1.34–5.29)] as well as serum IL-6 levels
[upper quartile [(HR = 3.37 (1.49–7.63)]) within the same models,
suggesting independent but approximately comparable effect size
on the hazard rate. A similar pattern is present for the effects of
oral health status on events when including serum levels of CRP,
but CRP level was not a significant effect modifier in adjusted
models. Thus, among the three inflammatory biomarkers serum
IL-6 has a significant interaction with oral health status to increase
the hazard rate for events when serum IL-6 levels are elevated. For
example, among edentate subjects with highest quartile of serum
IL-6, the Hazard ratio for COPD related events was 8.9.
However, based upon the data shown in Table 5, the effects of
oral disease and serum IL-6 on morbidity would not be expected
to be evident for all COPD GOLD Stages.
Table 3. Potential Explanatory Variables by COPD Related
Events.
Events (No) Events (Yes) p-value
1236 (75.6%) 399 (24.4%)
Perio/Edent
Health 365 (89.5%) 43 (10.5%)
Entry 403 (81.1%) 94 (18.9%)
Severe 221 (76.2%) 69 (23.8%)
Edentulous 247 (56.1%) 193 (43.9%) ,0.0001
Gold
I 763 (87.6%) 108 (12.4%)
II 413 (64.0%) 232 (36.0%)
III–IV 60 (50.4%) 59 (49.6%) ,0.0001
Center
Jackson 166 (83.4%) 33 (16.6%)
NC 365 (70.7%) 151 (29.3%)
Wash 350 (72.8%) 131 (27.2%)
Minn 355 (80.9%) 84 (19.1%) ,0.0001
African-American 197 (82.4%) 42 (17.6%)
Caucasian 1035 (74.4%) 356 (25.6%) 0.008
Age Mean (StdDev) 66.0 (5.13) 63.9 (5.69) ,0.0001
BMI Mean (StdDev) 27.1 (5.43) 27.3 (4.83) 0.36
Male 669 (71.9%) 261 (28.1%)
Female 567 (80.4%) 138 (19.6%) ,0.0001
Diabetic (Yes) 159 (65.7%) 83 (34.3%)
(No) 1072 (77.3%) 214 (22.7%) ,0.0001
Hypertension (Yes) 393 (69.6%) 172 (30.4%)
(No) 833 (78.7%) 225 (21.3%) ,0.0001
Smoking
Never 403 (94.6%) 23 (5.4%)
Former 587 (74.3%) 203 (25.7%)
Current 239 (58.6%) 169 (41.4%) ,0.0001
Pack Years Mean (StdDev) 22.4 (24.8) 47.0 (27.2) ,0.0001
Income
Low 368 (69.3%) 163 (30.7%)
Medium 444 (75.3%) 146 (24.8%)
High 373 (83.6%) 73 (16.4%) ,0.0001
Education
Basic 224 (61.9%) 138 (38.1%)
Intermediate 536 (77.0%) 160 (23.0%)
Advanced 475 (82.6%) 100 (17.4%) ,0.0001
doi:10.1371/journal.pone.0068592.t003
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Figure 3a illustrates the Kaplan-Meier survival function for
quartiles of serum IL-6 stratified by GOLD Stage. The effects of
elevated IL-6 on COPD events is evident among subjects with
GOLD stage I and GOLD stage II, but not for GOLD stage III/
IV. A significant gradient for increased risk for events with
increasing IL-6 levels (by quartile) was observed in subjects with
GOLD stage I and II disease (p = 0.004 and p = 0.008, respec-
tively). No effects are significant for CRP levels for any of the
GOLD stages in Figure 3B. These data suggest that serum levels of
IL-6 independently contribute to COPD-related events among
those with GOLD stage I and GOLD stage II disease.
Discussion
In this population-based longitudinal study, we observed a
statistically significant association between oral health status and
COPD-related events, even adjusting for conditions such as
hypertension and diabetes. Spirometry values were used to
determine GOLD stage as described in the Methods section. As
shown in Table 1, incidence of COPD-related events had a
monotonic positive association with GOLD stage ranging from
12.4% for individuals with a GOLD stage of I to 49.6% for those
with a GOLD stage of III/IV.
Edentulism and COPD-Related Events
We found that edentulous (total loss of teeth) individuals who
had been diagnosed with COPD had a higher incidence and were
at greater risk (HR = 2.28 and 95% CI = 1.46–3.56) of having a
COPD related event (hospitalization and death) than individuals
who had teeth and whose mouths had healthy periodontal status
(tables 1 and 2). This excess risk was independent of the effects of
age, race, sex, field center, smoking, pack years, hypertension,
education, and BMI. In additional, fully adjusted models, we
found that being edentulous conveyed excess risk for COPD-
Figure 2. Product-Limit Survival Estimates.
doi:10.1371/journal.pone.0068592.g002
Table 4. Hazard Ratios for COPD Related Events.
Hazard Ratio (95% Conf. Limit)
Unadjusted Adjusted*
Periodontal Health Ref Ref
Periodontal Entry 1.90 (1.28–2.83) 1.37 (0.89–2.12)
Periodontal Severe 2.22 (1.44–3.41) 1.34 (0.83–2.18)
Edentulous 4.66 (3.21–6.78) 2.28 (1.46–3.56)
*Adjusted for Race/Center (5-levels), Gender and Age, Smoking (3-levels), Pack
Years, Hypertension, Education (3-levels) and BMI.
doi:10.1371/journal.pone.0068592.t004
Table 5. Hazard Ratios for COPD Related Events Stratified by
GOLD Stage.
Hazard Ratio (95% Conf. Limit)
Unadjusted Adjusted*
GOLD I
Periodontal Health Ref Ref
Periodontal Entry 2.38 (1.21–4.68) 1.85 (0.86–4.01)
Periodontal Severe 2.49 (1.18–5.26) 1.53 (0.64–3.63)
Edentulous 5.06 (2.60–9.85) 2.37 (1.03–5.45)
GOLD II
Periodontal Health Ref Ref
Periodontal Entry 1.60 (0.91–2.81) 1.17 (0.64–2.13)
Periodontal Severe 2.02 (1.12–3.64) 1.34 (0.70–2.58)
Edentulous 3.51 (2.08–5.94) 2.12 (1.17–3.83)
GOLD III/IV
Periodontal Health Ref Ref
Periodontal Entry 0.69 (0.24–1.98) 0.69 (0.19–2.54)
Periodontal Severe 0.65 (0.13–3.22) 0.15 (0.02–1.35)
Edentulous 1.39 (0.56–3.44) 0.62 (0.16–2.39)
*Adjusted for Race/Center (5-levels), Gender and Age, Smoking (3-levels), Pack
Years, Hypertension, Education (3-levels) and BMI.
doi:10.1371/journal.pone.0068592.t005
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related events even when stratified by GOLD score for
individuals who were classified as GOLD stage I or GOLD
stage II at baseline (Table 3). However, being edentulous did
not convey excess risk for COPD-related events for those study
participants who were classified as GOLD III/IV at baseline.
Finally, we showed that edentulous individuals who had levels of
serum IL-6 in the highest two quartiles were at even higher risk
for COPD-related events. These findings suggest that the risk
for COPD-related events after adjusting for potential confound-
ers may be attributable to both edentulism and elevated serum
IL-6 levels.
There are a number of potential mechanisms that may underlie
this association and additional factors that may account for the
findings. Because COPD is associated with an abnormal
inflammatory response of the lung parenchyma to inhaled
pollutants and gases, an apparent explanation for the detection
of systemic inflammation on these patients was a hypothesis that
systemic inflammation in COPD was originating in a form of
‘‘spillover’’ of the pulmonary compartment, which has not been
proven [14].
However one reason for our finding that edentulism is
predictive of COPD-related events may be that more than 97%
of the study participants who had lost all of their teeth have
dentures and it is known that biofilm that forms on dentures can
house bacteria, yeasts and fungus that result in inflammatory
response from the oral tissues. Similar to the biofilm on natural
teeth, denture biofilm is complex due to the types and numbers of
organisms it contains, as well as its organized structure. Recently
Glass et al. reported on the complex nature of the microbial flora
contained within the denture biofilm, identifying over 900
individual species of aerobic and anaerobic bacteria, yeasts and
amoebae [9]. Others have reported similar complexities for the
microbial content of denture plaque [15]. It has also been long
recognized that unlike the dental biofilm, the biofilm that forms on
denture materials harbors a much larger population of yeasts, and
Candidal yeasts, and specifically Candida albicans, have been shown
to have strong pathogenic associations with the presence of
denture stomatitis [15,16,17,18,19,20] .
Since periodontal disease does lead to major tooth loss in a
subset of the population that have a strong inflammatory response
to infection, it is likely that infections on dentures will lead to a
similar inflammatory response. Thus, those study participants who
lost their teeth due to periodontal disease and have an
inflammatory response to the pathogens/fungus may be hyper-
inflammatory responders who are more susceptible to having
incident COPD-related events that lead to hospitalization and
death. Since reduction of most bacteria related to periodontal
disease is expected after full mouth tooth extraction, these
individuals may have reduced their systemic levels of inflammation
due to periodontal infections [21]. However, they may have
increased their overall risk for COPD related events via denture
biofilm accumulation, as suggested by the significant prevalence of
denture use in this studied edentulous population.
The increased levels of the inflammatory markers IL-6 and
CRP that parallel the severity of periodontal disease in association
with higher incidence of COPD-related events support a potential
systemic origin of the inflammation and, additionally, also strongly
suggest that edentulism is a relevant factor in the morbidity of
inflamed COPD patients.
Our study also indicated that while severe periodontal disease
was not significantly associated with COPD-related events among
study participants classified as GOLD stage III/IV, it was
significantly associated among those study participants with
GOLD stage I or II disease, even when adjusting for confounders
(Table 5). However, when either serum IL-6 or CRP was added to
the model, severe periodontal disease was no longer significantly
associated (Table 7).
One reason this may have occurred is that the majority of tooth
loss can be attributed to two conditions; dental caries and
periodontal disease, with periodontal disease tending to increase
with age and being responsible for the majority of tooth loss in a
Table 6. Quartiles of Serum Biomarkers by COPD Related
Events.
Event (No) Event (Yes) p-value
Serum IL-6
Quartile 1 135 (92.5%) 11 (7.5%)
Quartile 2 113 (77.4%) 33 (22.6%)
Quartile 3 102 (69.9%) 44 (30.1%)
Quartile 4 85 (58.2%) 61 (41.8%) ,0.0001
Serum CRP
Quartile 1 103 (83.7%) 20 (15.5%)
Quartile 2 96 (79.3%) 25 (20.7%)
Quartile 3 84 (68.9%) 38 (31.2%)
Quartile 4 77 (62.6%) 46 (37.4%) 0.0005
Serum sICAM-1
Quartile 1 115 (78.8%) 31 (21.2%)
Quartile 2 121 (82.9%) 25 (17.1%)
Quartile 3 101 (69.2%) 45 (30.8%)
Quartile 4 98 (67.1%) 48 (32.9%) 0.004
doi:10.1371/journal.pone.0068592.t006
Table 7. Hazard Ratios for COPD Related Events adding
Serum Biomarkers.
Hazard Ratio (95% Conf. Limit)
Unadjusted Adjusted*
Oral Condition + Serum IL-6
Periodontal Health Ref Ref
Periodontal Entry .. ..
Periodontal Severe 1.92 (1.03–3.55) 1.69 (0.85–3.36)
Edentulous 3.91 (2.20–6.95) 2.66 (1.34–5.29)
Serum IL-6 Q1 Ref Ref
Serum IL-6 Q2 2.69 (1.20–6.03) 2.12 (0.92–4.90)
Serum IL-6 Q3 3.85 (1.77–8.39) 3.14 (1.40–7.02)
Serum IL-6 Q4 5.17 (2.41–11.1) 3.37 (1.49–7.63)
Oral Condition + Serum CRP
Periodontal Health Ref Ref
Periodontal Entry .. ..
Periodontal Severe 2.31 (1.18–4.54) 1.65 (0.78–3.52)
Edentulous 5.04 (2.67–9.50) 3.17 (1.51–6.66)
Serum CRP Q1 Ref Ref
Serum CRP Q2 0.91 (0.47–1.79) 0.80 (0.40–1.60)
Serum CRP Q3 1.50 (0.82–2.75) 1.40 (0.73–2.66)
Serum CRP Q4 1.75 (0.97–3.14) 1.14 (0.61–2.15)
doi:10.1371/journal.pone.0068592.t007
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sub-group of the population. Periodontal disease has been
associated with a variety of systemic, inflammatory conditions and
there is evidence to indicate that components associated with host
immune and inflammatory responses as well as systemic exposure to
oral pathogens are involved [22,23]. Other studies have shown that
treating periodontal disease results in reduction of serum inflam-
matory biomarkers, indicating that periodontal disease may
enhance systemic inflammation [24,25]. Thus, if periodontal disease
and these serum biomarkers share the same causal pathway, it was
not surprising that severe periodontal disease was no longer
significant in individuals in the highest two quartiles of serum IL-
6 when being edentulous remained significant.
Our study design may be another potential reason that severe
periodontal disease did not remain significant in the model. The
oral examination was conducted only at the baseline of this study
and periodontal status may have changed. For example, study
participants may have sought treatment as a result of the
examination and their periodontal status improved; or their
periodontal status may have deteriorated and they lost all their
teeth and became edentulous; or participants who were healthy at
baseline may have acquired periodontal disease. Any of these
changes in periodontal status would have resulted in misclassifi-
cation of the exposure leading to bias towards the null. Conversely,
edentulous status would not have changed and would have
resulted in minimal, if any, misclassification of that potential
exposure.
An additional important contribution of this study is that after
adjusting for confounders including BMI, smoking status, race,
gender, hypertension and diabetes, IL-6 and CRP, which are two
key markers of chronic inflammation, showed association with oral
health conditions.
It also should be noted that this study sample is predominately a
middle age to older group [mean age 63.9 years old (SD = 5.69)].
Thus the incident rates of COPD-related events are higher than
would be found in the general US population. For example, the
incidence of hospitalization due to COPD during 2005 was
estimated to be 23.6 per 10,000 [26], while Table 1 reports the
incidence of COPD-related events to be 24.4 per hundred
individuals in this study. In addition to this being an older group,
everyone in this study had at least GOLD stage I disease. Thus,
the associations shown in this study may not be representative of
the entire US population.
Figure 3. Kaplan-Meier Quartiles of IL-6 Stratified on GOLD Stage.
doi:10.1371/journal.pone.0068592.g003
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In summary, the results of this population based study showed
that edentulism, which reflects a complex pattern of environmen-
tal, pathogenic and socioeconomic conditions, is predictive of
COPD-related events and thus provides further evidence support-
ing the notion that poor oral health is an important public health
issue.
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